News: CDY Cellmid Updates Market On COVID-19 Impact

March 27 (Reuters) - Cellmid Ltd (CDY) :

• PRUDENT TO WITHDRAW PREVIOUS GUIDANCE THAT IT WILL ACHIEVE OPERATIONAL PROFITABILITY FOR ITS CONSUMER BUSINESS BY END OF FY2020
• JAPANESE BUSINESS EXPECTED TO DELIVER ON BUDGET FOR SECOND HALF OF 2020 FINANCIAL YEAR
• DELIVERY OF CHINESE EXPORT ORDER NOW EXPECTED TO OCCUR IN TWO SPERATE SHIPMENTS IN APRIL AND MAY 2020
• OPERATIONAL EXPENDITURE OF CO REDUCED WHERE SENSIBLE
• RECENTLY SECURED SUPPLY OF WONDFO COVID-19 RAPID DIAGNOSTIC TEST IN AUSTRALIA
• CELLMID-AUSTRALIA PRODUCT LAUNCH PLANNED FOR MARCH IN PRICELINE HAS BEEN DELAYED, WILL START EFFECTING SALES FROM APRIL ONWARDS LOCALLY
• WILL SEPARATE LYRAMID INTO WHOLLY INDEPENDENT ENTITY BACKED BY INDEPENDENT FUNDING AND/OR PARTNERSHIP WITH BIOPHARMACEUTICAL CO BY 2020 END